Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03951194 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Autologous Platelet Rich Plasma (PRP) Intra Ovarian Infusion in Perimenopausal Women

Study acronym: PRP
StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jan 30, 2025 to Jan 30, 2027
    • Study completion date: Jul 30, 2025 to Jul 30, 2028
    v9
  2. Re-verified, no change to tracked fieldsv8
  3. Primary completion date: Jan 30, 2023 to Jan 30, 2025
    • Study completion date: Jan 30, 2023 to Jul 30, 2025
    v7
  4. Re-verified, no change to tracked fieldsv6
  5. Primary and study completion dates: Jan 30, 2021 to Jan 30, 2023v5 Show 6 more changesShow less
    • Primary endpoints revised (2)
    • Interventions: Autologous Platelet rich Plasma (Biological), Placebo (Other) to Autologous Platelet Rich Plasma (PRP) intra ovarian infusion (Biological), Placebo: Autologous Platelet Free Plasma (PFP) intra ovarian…
    • Eligibility criteria expanded, about 83 words
    • Secondary endpoints revised (5)
    • Study description shortened, about 4 words
    • Study title expanded, about 3 words
Show 3 earlier versionsHide 3 earlier versions
  1. Eligibility criteria expanded, about 9 wordsv4
  2. Site contact updatedv3
  3. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Start date changed from estimate of Jun 10, 2019 to Jun 13, 2019
    • Eligibility criteria revised
    • Site details revised
    • Study title expanded, about 2 words
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Autologous PRP intra ovarian infusion may improve ovarian response and women's hormonal profile and may promote folliculogenesis in perimenopausal women.
Trial Details
NCT Number NCT03951194
Lead Sponsor Genesis Athens Clinic
Collaborators: National and Kapodistrian University of Athens
Conditions
(from sponsor)		 Infertility, Female, Perimenopausal Disorder, Menstrual Cycle Abnormal
Related terms Infertility, Female
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov